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Preventing farnesylation of the dynein adaptor 
Spindly contributes to the mitotic defects caused 
by farnesyltransferase inhibitors
Andrew J. Hollanda,*, Rita M. Reisb,c, Sherry Niessend, Cláudia Pereirab,c, Douglas A. Andrese, 
H. Peter Spielmanne,f, Don W. Clevelanda, Arshad Desaia, and Reto Gassmannb,c
aLudwig Institute for Cancer Research/Department of Cellular and Molecular Medicine, University of California, San 
Diego, La Jolla, CA 92093; bInstituto de Biologia Molecular e Celular and cInstituto de Investigação e Inovação em 
Saúde-i3S, Universidade do Porto, Porto 4150-180, Portugal; dSkaggs Institute for Chemical Biology and Department 
of Chemical Physiology, Center for Physiological Proteomics, Scripps Research Institute, La Jolla, CA 92037; 
eDepartment of Molecular and Cellular Biochemistry and fDepartment of Chemistry, Markey Cancer Center, Kentucky 
Center for Structural Biology, University of Kentucky, Lexington, KY 40536
ABSTRACT The clinical interest in farnesyltransferase inhibitors (FTIs) makes it important to 
understand how these compounds affect cellular processes involving farnesylated proteins. 
Mitotic abnormalities observed after treatment with FTIs have so far been attributed to de-
fects in the farnesylation of the outer kinetochore proteins CENP-E and CENP-F, which are 
involved in chromosome congression and spindle assembly checkpoint signaling. Here we 
identify the cytoplasmic dynein adaptor Spindly as an additional component of the outer ki-
netochore that is modified by farnesyltransferase (FTase). We show that farnesylation of Spin-
dly is essential for its localization, and thus for the proper localization of dynein and its cofac-
tor dynactin, to prometaphase kinetochores and that Spindly kinetochore recruitment is 
more severely affected by FTase inhibition than kinetochore recruitment of CENP-E and 
CENP-F. Molecular replacement experiments show that both Spindly and CENP-E farnesyl-
ation are required for efficient chromosome congression. The identification of Spindly as a 
new mitotic substrate of FTase provides insight into the causes of the mitotic phenotypes 
observed with FTase inhibitors.
INTRODUCTION
A wide variety of proteins, including RAS, pre–lamin A, fungal pher-
omones, and rhodopsin kinase, depend on posttranslational prenyl-
ation for proper localization and activity. Prenylated proteins are 
modified by either farnesyltransferase (FTase) or geranylgeranyl-
transferase (GGTase), which covalently link a 15- or 20-carbon 
isoprenoid moiety to a C-terminal cysteine via a thiolether bond, 
with farnesyl diphosphate (FPP) and geranylgeranyl diphosphate 
(GGPP) acting as the lipid donors (Pechlivanis and Kuhlmann, 2006; 
Nguyen et al., 2010; Zverina et al., 2012). FTase and GGTase type 1 
have been proposed to recognize protein substrates containing a 
C-terminal CAAX box, where C refers to the modified cysteine resi-
due, A is any aliphatic amino acid, and X refers to a subset of amino 
acids that determine whether the cysteine receives a farnesyl or ge-
ranylgeranyl group. Besides facilitating association with mem-
branes, the farnesyl/geranylgeranyl moiety has also been shown to 
be involved in the regulation and modulation of protein–protein in-
teractions (Hoffman et al., 2000; Rak et al., 2003; Rotblat et al., 
2004; Pylypenko et al., 2006; Ignatev et al., 2008).
Oncogenic mutations in the RAS genes constitutively activate 
GTPase activity, leading to uncontrolled proliferation. Farnesylation 
is required for the translocation of RAS to the plasma membrane 
and subsequent activation of cellular signaling. The promise of in-
hibiting the membrane translocation of oncogenic RAS spurred the 
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down with only one of the two antibodies (Figure 1A and Supple-
mental Figure S1). We conclude that a mitotic pool of human 
Spindly associates with FTase.
Sequence inspection revealed that Spindly contains an atypical 
variant of the C-terminal CAAX box (Hougland et al., 2009) that is 
conserved from vertebrates to fungi (Figure 1B). Of interest, the mo-
tif appears to have been lost in a subset of phyla, including the in-
vertebrate chordate group amphioxus (Branchiostoma floridae), 
hemichordates (Saccoglossus kowalevskii), insects (Drosophila 
melanogaster), nematodes (Caenorhabditis elegans), and cnidaria 
(Hydra magnipapillata).
The physical association of Spindly with FTase and the conserva-
tion of the C-terminal farnesylation motif suggested that Spindly may 
be modified by FTase. To test this directly, we incubated cells with 
anilinogeraniol (AGOH; Figure 1C), which is converted to the unnatu-
ral, competitive FPP analogue anilinogeranyl diphosphate (AGPP) 
and incorporated into proteins by FTase (Troutman et al., 2005). The 
AG moiety in proteins can subsequently be detected with specific 
polyclonal anti- AG antibodies. Consistent with farnesylated proteins 
being present at kinetochores, we detected AG signal at kineto-
chores by immunofluorescence (Supplemental Figure S2A). To assess 
farnesylation of both endogenous and transgenic Spindly by immu-
noblot, we used HeLa cell lines in which tetracycline-inducible 
MycGFP::Spindly constructs were integrated into a specific genomic 
locus by Flp-mediated DNA recombination (O’Gorman et al., 1991). 
We had previously implemented this system for the study of Spindly 
mutants (Gassmann et al., 2010). As a negative control, we mutated 
the putative farnesylated cysteine residue to serine (C602S). We 
incubated cells with tetracycline and AGOH for 48 h in the presence 
or absence of the FTase inhibitor FTI-277 before preparing cell lysates 
and immunoprecipitating transgene-encoded Spindly with anti-Myc 
antibodies (Figure 1C). Immunoblotting with anti-Spindly antibodies 
revealed that endogenous Spindly efficiently coimmunoprecipitated 
with MycGFP::Spindly (Figure 1D), suggesting that Spindly is present 
as an oligomer in cells. FTI-277 treatment had no effect on Spindly 
expression levels, nor did it change the amount of endogenous Spin-
dly that coimmunoprecipitated with Myc-tagged Spindly. Probing 
the same immunoblot with anti-AG antibodies revealed efficient la-
beling of multiple farnesylated proteins in total cell lysates (input 
lanes). MycGFP::SpindlyWT, but not MycGFP::SpindlyC602S, was 
clearly detectable with anti-AG antibodies in both input and immu-
noprecipitated fractions. In addition, endogenous Spindly that coim-
munoprecipitated with transgene-encoded Spindly could be de-
tected with anti-AG antibodies in both MycGFP::SpindlyWT– and 
MycGFP::SpindlyC602S–expressing cells. Treatment with FTI-277 abol-
ished all anti-AG signal in cell lysates and immunoprecipitated frac-
tions, demonstrating that AG incorporation into proteins is depen-
dent on FTase activity. We conclude that Spindly is modified by FTase.
We also examined the farnesylation of endogenous CENP-E in 
human DLD-1 cells and Xenopus egg extracts using the AG labeling 
approach (Supplemental Figure S2, B and C). Endogenous CENP-E 
incorporated AG after treatment with dimethyl sulfoxide (DMSO) 
but not in the presence of FTI-277. In addition, MycGFP-tagged hu-
man CENP-E incorporated AG, whereas the farnesylation mutant 
C2261S did not (Supplemental Figure S2D). Together, these data 
confirm previous reports that CENP-E is farnesylated (Ashar et al., 
2000; Gurden et al., 2010).
Spindly farnesylation is required for its 
kinetochore localization
It has been reported that CENP-E and CENP-F require farnesylation 
for efficient targeting to kinetochores (Hussein and Taylor, 2002; 
development of potent farnesyltransferase inhibitors (FTIs; Crul 
et al., 2001). However, studies with these inhibitors revealed that RAS 
undergoes alternative geranylgeranylation that is capable of promot-
ing membrane translocation in the presence of FTIs (Berndt et al., 
2011). This has limited the clinical use of FTIs as anticancer agents, 
although recent evidence suggests that FTIs may be valuable in the 
treatment of malignant hematological disease (Berndt et al., 2011; 
Holstein and Hohl, 2012). Of importance, the use of FTIs is not lim-
ited to cancer therapeutics: inhibition of FTase has gained interest as 
an approach for fighting parasites (Eastman et al., 2006), and FTIs 
have shown promise for the treatment of Hutchinson–Gilford proge-
ria syndrome, a disease caused by the aberrant accumulation of a 
farnesylated form of lamin A (Yang et al., 2011; Gordon et al., 2014).
The medical relevance of FTIs makes it important to identify the 
cellular substrates of FTase. Most human tumor cells lines that are 
sensitive to FTI treatment exhibit a defect in chromosome congres-
sion that leads to an accumulation in the mitotic phase of the cell 
cycle (Moasser et al., 1998; Ashar et al., 2000; Crespo et al., 2001; 
Schafer-Hales et al., 2007). This effect has been attributed to non-
farnesylated CENP-E and CENP-F, which are the only mitotic sub-
strates of FTase known to date. Both CENP-E, a microtubule plus 
end–directed kinesin, and CENP-F, a coiled-coil protein implicated 
in the recruitment of cytoplasmic dynein, localize to mitotic kineto-
chores, where they are involved in mediating attachments to spindle 
microtubules that drive chromosome segregation (Weaver et al., 
2003; Bomont et al., 2005; Feng et al., 2006; Liang et al., 2007; 
Vergnolle et al., 2007; Kim et al., 2008). Farnesylation of CENP-E 
and CENP-F is required for their APC/C-mediated degradation at 
mitotic exit by the proteasome (Hussein and Taylor, 2002; Gurden 
et al., 2010). In addition, kinetochore localization of CENP-E and 
CENP-F has been reported to be impaired after FTase inhibition in 
some studies (Hussein and Taylor, 2002; Schafer-Hales et al., 2007) 
but not others (Ashar et al., 2000; Crul et al., 2001; Verstraeten et al., 
2011). Thus the contribution from the lack of CENP-E and CENP-F 
farnesylation to the mitotic phenotype of FTIs remains unclear.
Spindly is a kinetochore-specific adaptor for cytoplasmic dynein 
(Griffis et al., 2007; Chan et al., 2009; Barisic et al., 2010; Gassmann 
et al., 2010) that, like CENP-E and CENP-F, localizes to the fibrous 
corona, the outermost domain of the kinetochore, and is removed 
from microtubule-attached kinetochores by dynein-mediated trans-
port to spindle poles. Here we identify Spindly as a novel substrate 
of FTase in human cells. We demonstrate that Spindly physically in-
teracts with FTase and show that farnesylation is required for Spindly 
accumulation at kinetochores. Functional replacement experiments 
show that preventing farnesylation of Spindly and CENP-E delays 
chromosome congression, producing a phenotype similar to that 
observed in cells treated with FTIs. The identification of Spindly as a 
novel farnesylated kinetochore protein provides mechanistic insight 
into the biological effect of FTIs.
RESULTS
The kinetochore protein Spindly is a substrate 
of farnesyltransferase
To identify binding partners of human Spindly, we immunoprecipi-
tated Spindly from mitotic HeLa cell extracts using two affinity-puri-
fied polyclonal antibodies raised against nonoverlapping epitopes 
in the N- and C-terminal halves of the protein (Figure 1A). Both an-
tibodies immunoprecipitated Spindly with similar efficiency (Supple-
mental Figure S1), and mass spectrometric analysis identified the α 
and β subunits of FTase in a search for proteins that coimmunopre-
cipitated with both antibodies (Figure 1A). By contrast, the known 
kinetochore components Mad1-Mad2 and CENP-F were pulled 
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(p150, 65 ± 10% of DMSO control) in nocodazole-treated HeLa cells 
after incubation with FTI-277 (Figure 3, A, B, and E). We also ob-
served a reduction of kinetochore dynein and dynactin levels in cells 
expressing MycGFP::SpindlyC602S to 66 ± 5% for dynein and 55 ± 8% 
for dynactin relative to cells expressing MycGFP::SpindlyWT (Figure 
3, C, D, and F). CENP-F is known to contribute to kinetochore dy-
nein recruitment through the dynein cofactor NudE/L (Liang et al., 
2007; Stehman et al., 2007; Vergnolle and Taylor, 2007). To assess 
whether the inhibition of CENP-F farnesylation could be contribut-
ing to the decrease of dynein/dynactin levels at kinetochores ob-
served in FTI-treated cells, we added FTI-277 to cells expressing 
MycGFP::SpindlyC602S. The FTI-277 treatment did not result in a sig-
nificant additional decrease in dynein/dynactin levels (Figure 3F). 
We conclude that inhibition of FTase reduces kinetochore levels of 
dynein/dynactin and that this reduction is primarily a consequence 
of preventing Spindly farnesylation.
CENP-E farnesylation is important for 
chromosome segregation
Previous work showed that farnesylation is required for the degrada-
tion of CENP-E upon mitotic exit (Gurden et al., 2010). To determine 
whether CENP-E farnesylation contributes to chromosome segrega-
tion, we took advantage of an RNAi-based replacement strategy 
that we had established for CENP-E in DLD-1 cells (Kim et al., 2010). 
We knocked down endogenous CENP-E with small interfering RNAs 
(siRNAs) directed against the 3′ untranslated region of CENP-E 
mRNA and induced expression of RNAi-resistant CENP-E trans-
genes with tetracycline (Figure 4A). Immunoblotting confirmed 
efficient replacement of endogenous CENP-E with the transgene-
encoded protein (Figure 4B), and endogenous CENP-E was unde-
tectable at kinetochores in cells treated with CENP-E siRNAs by im-
munofluorescence (Figure 4C). We then monitored chromosome 
segregation by time-lapse microscopy in cells coexpressing histone 
H2B::mRFP. Depletion of CENP-E increased the average time cells 
spent in mitosis, defined as the interval between nuclear envelope 
breakdown and the onset of anaphase, from 58 min to 244 min on 
average (Figure 4D). This mitotic delay was largely rescued by 
MycGFP::CENP-EWT (67 min on average) but not when we replaced 
endogenous CENP-E with the motor-dead rigor mutant T93N 
(500 min on average), consistent with previously published data 
(Kim et al., 2010). Replacement of endogenous CENP-E with the 
farnesylation mutant C2261S led to a mitotic delay (120 min on aver-
age), which was less pronounced than that observed in cells treated 
with FTI-277 (177 min on average; Figure 4E). Combining the CENP-
E C2261S mutant with FTI-277 treatment resulted in a mitotic delay 
that was equal to FTI-277 treatment on its own (178 min on aver-
age). Inspection of the time-lapse movies confirmed that the mitotic 
delay in cells treated with FTI-277 was caused by a defect in chro-
mosome congression, similar to what was observed in CENP-E–de-
pleted cells and in cells in which endogenous CENP-E was replaced 
with the CENP-E C2261S mutant (Figure 4F). These results demon-
strate that farnesylation of CENP-E is required for chromosome con-
gression and timely mitotic progression but that inhibition of CENP-
E farnesylation alone cannot fully account for the mitotic phenotype 
observed in cells treated with farnesyltransferase inhibitors.
A C-terminal CENP-E fragment (amino acids 1569–2264), called 
the CENP-E tail, contains the kinetochore-binding domain and 
causes a pronounced mitotic arrest when overexpressed (Chan 
et al., 1998; Gurden et al., 2010; Supplemental Figure S5, A and B). 
The mitotic delay in cells expressing the CENP-E tail in the presence 
of endogenous CENP-E (1231 min on average) was significantly 
more severe than in CENP-E–depleted cells (244 min on average; 
Schafer-Hales et al., 2007). To determine whether Spindly localiza-
tion to kinetochores requires FTase activity, we treated HeLa and 
DLD-1 cells with FTI-277 and monitored Spindly localization by im-
munofluorescence. Microtubules were depolymerized with no-
codazole, which causes Spindly and other components of the fi-
brous corona to accumulate at kinetochores (Hoffman et al., 2001). 
In DMSO-treated cells arrested in mitosis with nocodazole, Spindly 
adopted the expected crescent morphology at kinetochores (Figure 
2A and Supplemental Figure S3A). By contrast, treatment with FTI-
277 reduced Spindly levels at kinetochores to 17 ± 3% (average ± 
SEM with 95% confidence interval) in HeLa cells and to 17 ± 5% in 
DLD-1 cells (Figure 2, A and D, and Supplemental Figure S3, A and 
E). Under the same conditions, CENP-E kinetochore levels were re-
duced to 56 ± 7% in HeLa cells and 31 ± 7% in DLD-1 cells, whereas 
CENP-F kinetochore levels were less affected, with a reduction to 73 
± 10% in HeLa cells and 56 ± 10% in DLD-1 cells. (Figure 2, B–D, and 
Supplemental Figure S3, B, C, and E). Kinetochore levels of Zwilch, 
a subunit of the ROD/Zw10/Zwilch complex (Karess, 2005; Çivril 
et al., 2010) that is required for kinetochore recruitment of Spindly, 
were also reduced by FTI-277 treatment (80 ± 9% in HeLa cells; 
Figure 2, E and G). By contrast, kinetochore levels of Hec1, a com-
ponent of the KMN network that forms the core microtubule attach-
ment site at the outer kinetochore (Cheeseman et al., 2006), were 
not affected by FTI-277 treatment in either cell line (99 ± 12% and 
98 ± 12% in HeLa and DLD-1 cells, respectively; Figure 2, F and G, 
and Supplemental Figure S3, D and E). We conclude that FTase ac-
tivity is a major requirement for kinetochore targeting of Spindly. 
CENP-E and CENP-F also require farnesylation for proper kineto-
chore localization, but Spindly targeting to kinetochores is more se-
verely affected by inhibition of farnesylation.
To test directly whether farnesylation of Spindly and CENP-E is 
required for their recruitment to kinetochores, we examined the lo-
calization of farnesylation mutants. In the absence of nocodazole, 
RNA interference (RNAi)–resistant MycGFP::SpindlyWT localized ro-
bustly to prometaphase kinetochores after RNAi-mediated deple-
tion of endogenous Spindly, as expected (Gassmann et al., 2010; 
Supplemental Figure S4A). By contrast, MycGFP::SpindlyC602S was 
essentially undetectable at kinetochores of prometaphase cells in 
the presence of microtubules (Supplemental Figure S4A), confirm-
ing the finding of a previous study that discussed the possibility that 
Spindly is farnesylated (Barisic et al., 2010). However, analysis in cells 
treated with nocodazole showed that the C602S mutant does retain 
some ability to target to kinetochores in the absence of microtubule 
attachment (Figure 2, H and I). Quantification of immunofluores-
cence signals revealed that the reduction in kinetochore levels of 
MycGFP::SpindlyC602S (20 ± 3% of MycGFP::SpindlyWT) was similar to 
the reduction observed for endogenous Spindly after FTI-277 treat-
ment (17 ± 3% of DMSO control). The MycGFP::CENP-EC2261S mu-
tant expressed in DLD-1 cells also showed reduced kinetochore 
levels (45 ± 13% of MycGFP::CENP-EWT), which were not signifi-
cantly different from kinetochore levels of MycGFP::CENP-EWT after 
FTI-277 treatment (33 ± 8% of DMSO control; Supplemental Figure 
S4, B and C). We conclude that modification by FTase is required for 
proper kinetochore targeting of Spindly and CENP-E.
Inhibition of farnesylation impairs kinetochore recruitment 
of dynein and dynactin
Spindly is required to target dynein and its cofactor dynactin to the 
kinetochore, predicting that these proteins should be among the 
kinetochore components whose levels are affected by FTI treat-
ment. Indeed, we observed a significant decrease in kinetochore 
levels of both dynein (DIC, 61 ± 8% of DMSO control) and dynactin 
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FIGURE 1: Human Spindly interacts with and is modified by farnesyltransferase. (A) Results of mass spectrometric 
analysis of immunoprecipitates from mitotic HeLa cells with two affinity-purified antibodies raised against nonoverlapping 
N- and C-terminal epitopes of Spindly (amino acids 2–254 and 450–605). Sequence coverage and spectrum count for 
selected proteins are shown. (B) Sequence alignment of Spindly C-termini in eukaryotes showing widespread 
conservation of a putative farnesylation motif that deviates from the canonical CAAX box (Hougland et al., 2009). The 
amino acid number of the fifth residue from the C-terminus is indicated. The farnesyl cysteine is present in vertebrates 
(represented by Homo sapiens, Mus musculus, Gallus gallus, Xenopus laevis, Danio rerio). In the two invertebrate 
chordate groups, the motif is present in tunicates (Ciona intestinalis) but is absent in amphioxus (B. floridae). Of the two 
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FIGURE 2: Farnesylation of Spindly is required for its localization to microtubule-unattached kinetochores. (A–C) HeLa 
cells immunostained for the kinetochore proteins Spindly (A), CENP-E (B), and CENP-F (C) after treatment for 48 h with 
10 μM farnesyltransferase inhibitor FTI-277 or DMSO. Cells were incubated in 1 μM nocodazole for 4 h to maximize the 
accumulation of the proteins at kinetochores and costained with anti-centromere antibodies (ACAs). Scale bars, 5 μm. 
(D) Quantification of protein levels at kinetochores in the conditions shown in A–C using immunofluorescence intensity 
measurements. Each condition represents a total of 100 kinetochore measurements from 20 different cells. Error bars 
represent the SEM with a 95% confidence interval. The t test was used to determine statistical significance (***p < 0.0001). 
(E, F) HeLa cells immunostained for the kinetochore proteins Zwilch (E) and Hec1 (F) after treatment for 48 h with 10 μM 
farnesyltransferase inhibitor FTI-277 or DMSO. Scale bars, 5 μm. (G) Kinetochore level quantification of the conditions in E 
and F displayed as described for D (ns, not statistically significant). (H) Kinetochore localization of RNAi-resistant, 
MycGFP-tagged wild-type (WT) and mutant (C602S) Spindly in nocodazole-treated HeLa cells after depletion of 
endogenous Spindly, visualized by immunofluorescence with an anti-GFP antibody (see Figure 5A for corresponding RNAi 
immunoblot). Scale bar, 5 μm. (I) Kinetochore level quantification of the condition in H displayed as described for D.
closest nonchordate invertebrate relatives of amphioxus, echinoderms (Strongylocentrotus purpuratus) have the motif 
but hemichordates do not (S. kowalevskii). We could not find the motif in insects (D. melanogaster), nematodes 
(C. elegans), or cnidaria (H. magnipapillata). However, the motif appears in the primitive multicellular animal Trichoplax 
adhaerens, the only extant member of Placozoa, as well as in choanoflagellates (Monosiga brevicollis, Salpingoeca 
spinifera), the closest unicellular relatives of multicellular animals. The motif is also present in the chytrid fungus 
Batrachochytrium dendrobatidis. (C) Schematic of experimental approach for the detection of farnesylated Spindly based 
on in vivo labeling with the unnatural farnesyl diphosphate analogue AGOH and AG-specific antibodies. (D) Immunoblots 
detecting endogenous and transgenic Spindly and corresponding AG signals in cell lysate input fractions (I) and fractions 
obtained after immunoprecipitation with anti-Myc tag antibody (Myc) or beads-only controls (Con).
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FIGURE 3: Farnesyltransferase inhibition or prevention of Spindly farnesylation impairs kinetochore recruitment of 
dynein and its cofactor dynactin. (A–D) HeLa cells immunostained for dynein IC (DIC) and the dynactin subunit p150Glued 
in cells treated with FTI-277 or DMSO (A, B) and in cells expressing wild-type (WT) and mutant (C602S) MycGFP::Spindly 
after RNAi-mediated depletion of endogenous Spindly (C, D). Cells were incubated in 1 μM nocodazole for 4 h to 
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The fibrous corona thus harbors multiple microtubule-binding activi-
ties that are required for efficient chromosome congression. Our 
analysis shows that FTI treatment selectively perturbs the formation 
of this kinetochore domain, whereas the core microtubule attach-
ment site (represented in our experiments by Hec1) assembles nor-
mally. Although changes in kinetochore morphology are difficult to 
quantify, we found that the telltale crescent and ring shapes of mi-
crotubule-unattached kinetochores (Hoffman et al., 2001) were 
largely missing when staining for fibrous corona components after 
FTI-277 treatment. Thus the decreased kinetochore levels of corona 
components in the presence of FTIs may partially reflect the inability 
of the fibrous corona domain to undergo expansion. Among the 
three farnesylated kinetochore components, the localization of Spin-
dly was the most dramatically affected by FTI treatment. We find 
that the kinetochore recruitment of Spindly requires its farnesylation, 
raising the possibility that the farnesyl moiety at the Spindly C-termi-
nus is necessary for the interaction with a kinetochore receptor. Spin-
dly kinetochore recruitment depends on the Rod/Zw10/Zwilch com-
plex, and the C-terminus of human Spindly is positioned close to 
Zwilch, Zw10, and the N-terminus of Rod, as determined by nano-
meter-scale immunofluorescence mapping experiments (Varma 
et al., 2013). It will be interesting to investigate whether Spindly 
farnesylation is required for binding to the Rod/Zw10/Zwilch com-
plex. However, since the critical cysteine required for Spindly farne-
sylation is not present in all phyla, there are likely other conserved 
regions of Spindly that participate in its kinetochore targeting. 
Nevertheless, our work indicates that future biochemical reconstitu-
tion efforts of kinetochore complexes involving vertebrate Spindly 
will need to take into account the key role of its farnesyl group.
There are contradictory reports regarding the contribution of 
farnesylation to the kinetochore recruitment of CENP-E and CENP-
F, as previous studies did not measure kinetochore levels of these 
proteins (Ashar et al., 2000; Crespo et al., 2001; Hussein and Taylor, 
2002; Schafer-Hales et al., 2007; Verstraeten et al., 2011). Our ex-
periments in HeLa and DLD-1 cells demonstrate that both CENP-E 
and CENP-F require farnesylation for proper localization to microtu-
bule-unattached kinetochores, although their localization is less af-
fected by FTase inhibition than Spindly. We found that inhibition of 
FTase also affects the localization of the ROD/Zw10/Zwilch complex, 
which targets to the KMN network upstream of Spindly. The expan-
sion of the fibrous corona in the absence of microtubules is not un-
derstood at the molecular level, but it is evident that the expansion 
step must involve interactions among corona components that are 
distinct from the interactions that mediate the initial recruitment by 
the KMN network, which itself does not expand. One interpretation 
of our results is that the kinetochore accumulation of the ROD/
Zw10/Zwilch complex in the absence of microtubules is in part facili-
tated by interactions with CENP-E, CENP-F, or Spindly, whose ki-
netochore recruitment is directly affected by FTI treatment.
Our molecular replacement experiments establish that both non-
farnesylated CENP-E and nonfarnesylated Spindly cause chromo-
some congression defects and contribute to the delay in mitotic pro-
gression that is observed after FTI treatment. Assessing the functional 
significance of CENP-F farnesylation for chromosome segregation 
will necessitate the development of a molecular replacement 
compare Figure 4D with Supplemental Figure S5B), suggesting that 
the CENP-E tail is a gain-of-function mutant, possibly acting through 
chronic activation of spindle assembly checkpoint signaling (Mao 
et al., 2005). Strikingly, we observed that the dominant-negative ef-
fect of the CENP-E tail depends entirely on its modification by 
FTase: expression of the CENP-E tail farnesylation mutant C2261S 
had no adverse effect on mitotic duration (65 min on average), and 
treatment with FTI-277 reduced the mitotic duration of cells ex-
pressing the CENP-E tail from 1231 min to 210 min on average, 
which is close to the mitotic duration observed in FTI-277-treated 
cells (177 min on average; Figure 4E and Supplemental Figure S5, A 
and B). Furthermore, the C2261S mutation rescued the penetrant 
lethality of CENP-E tail expression in a clonogenic survival assay 
(Supplemental Figure S5C). This effect would not have been pre-
dicted from the comparatively mild functional consequences of in-
hibiting farnesylation of wild-type CENP-E and serves to demon-
strate that inhibition of farnesylation can dramatically alter toxic 
properties of mutant proteins.
Preventing farnesylation of Spindly and inhibition of 
farnesyltransferase activity result in a similar mitotic 
phenotype
The loss of Spindly from kinetochores after FTI-277 treatment indi-
cated that nonfarnesylated Spindly contributes to the mitotic phe-
notype of FTase inhibitors. We tested this hypothesis by combining 
specific depletion of endogenous Spindly with expression of RNAi-
resistant MycGFP::Spindly transgenes in HeLa cells coexpressing 
H2B::mRFP (Figure 5A). As expected from previous work, the mi-
totic delay induced by depletion of Spindly (79 min on average) was 
largely rescued by ectopic expression of MycGFP::SpindlyWT (40 vs. 
28 min on average for control cells; Gassmann et al., 2010; Figure 
5B). Expression of the MycGFP::SpindlyC602S mutant caused a mi-
totic delay (64 min on average), which was slightly less pronounced 
than that observed in FTI-277-treated cells (71 min on average). Vi-
sualization of chromosome segregation confirmed that the mitotic 
delay in cells expressing the MycGFP::SpindlyC602S mutant was 
caused by misaligned chromosomes, a defect characteristic of Spin-
dly depletions (Chan et al., 2009; Barisic et al., 2010; Gassmann 
et al., 2010; Figure 5C). We conclude that farnesylation of Spindly is 
required for efficient recruitment of dynein/dynactin to kinetochores 
and timely chromosome congression.
DISCUSSION
FTase inhibitors (FTIs) are increasingly regarded as promising agents 
for therapeutic intervention in a variety of diseases, which makes the 
identification of a complete catalogue of FTase substrates an impor-
tant goal. Previously it was shown that FTase inhibition leads to mi-
totic defects that have been largely attributed to a lack of farnesyl-
ation of the mitotic proteins CENP-E and CENP-F. Our study now 
identifies Spindly as a third farnesylated mitotic protein and shows 
that preventing farnesylation of Spindly is a major contributor to the 
mitotic phenotype of FTIs.
CENP-E, CENP-F, and Spindly all localize to the fibrous corona at 
the outer kinetochore, where Spindly and CENP-F are responsible 
for the recruitment of cytoplasmic dynein and its cofactor dynactin. 
maximize the accumulation of the proteins at kinetochores and costained with ACAs. Scale bars, 5 μm. 
(E, F) Quantification of dynein and dynactin levels at kinetochores in the conditions shown in A–D, as well as in the 
Spindly mutant C602S after treatment with FTI-277, using immunofluorescence intensity measurements. Each condition 
represents a total of 100 kinetochore measurements from 20 different cells. Error bars represent the SEM with a 95% 
confidence interval. The t test was used to determine statistical significance (***p < 0.0001; ns, not significant).
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FIGURE 4: CENP-E farnesylation is important for chromosome segregation. (A) Experimental approach for the 
characterization of DLD-1 Flp-In T-Rex cells with integrated RNAi-resistant CENP-E constructs whose expression is 
inducible with tetracycline. (B) Immunoblot showing successful replacement of endogenous CENP-E with RNAi-resistant 
MycGFP::CENP-E in DLD-1 cells. C2261S corresponds to the CENP-E farnesylation mutant and T93N to motor-dead 
“rigor” CENP-E. α-Tubulin was used as a loading control. (C) Immunofluorescence of DLD-1 cells showing loss of 
kinetochore-localized CENP-E 48 h after transfection with CENP-E siRNA. Cells were costained with ACAs. Scale bar, 
5 μm. (D) Quantification of mitotic duration (nuclear envelope breakdown to anaphase onset) from time-lapse 
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Immunoprecipitations and mass spectrometry
For mass spectrometry analysis of Spindly immunoprecipitates, en-
dogenous Spindly was immunoprecipitated with 50 μg of affinity-
purified anti-Spindly antibody OD173 or OD174 (covalently coupled 
to 100 μl of agarose protein A beads [BioRad, Hercules, CA]) from a 
mitotic HeLa cell extract (30 mg of total protein). The extract was 
prepared by sonicating nocodazole-arrested cells (harvested by mi-
totic shake-off) in lysis buffer (50 mM 4-(2-hydroxyethyl)-1-pipera-
zineethanesulfonic acid [HEPES], pH 7.6, 200 mM KCl, 1 mM MgCl2, 
1 mM ethylene glycol tetraacetic acid [EGTA], 5% glycerol, 0.05% 
NP-40, 1 mM dithiothreitol [DTT], 5 mM β-glycerophosphate, 400 nM 
microcystin, and cOmplete protein inhibitor cocktail [Roche, Basel, 
Switzerland]), followed by sequential rounds of centrifugation in an 
ultracentrifuge at 20,000 and 50,000 × g. Beads were washed with 
6 × 1 ml of lysis buffer and 3 × 1 ml of lysis buffer without detergent. 
Proteins were eluted from beads with 0.1 M glycine, pH 2.6, and the 
samples neutralized with 2 M Tris-HCl, pH 8.5. Proteins were precipi-
tated by addition of 1/5 volume trichloroacetic acid (TCA) overnight 
on ice, and the TCA pellet was washed twice with acetone before 
air-drying. Mass spectrometry was conducted as described previ-
ously (Cheeseman et al., 2004).
For immunoprecipitations from HeLa cells after labeling with the 
farnesol analogue AGOH, unsynchronized cells (one 15-cm dish per 
condition) were harvested, washed with 1× phosphate-buffered sa-
line (PBS), and sonicated in 3 ml of lysis buffer (50 mM HEPES, pH 7.4, 
200 mM KCl, 1 mM EGTA, 1 mM MgCl2, 0.05% NP-40, 1 mM DTT, 
5 mM β-glycerophosphate, and protease inhibitors). The crude ly-
sate was clarified by spinning at 20,000 × g for 10 min, and 1.3 ml of 
the cleared lysate was incubated with 5 μg of anti-Myc tag antibody 
(clone 4A6) covalently coupled to 10 μl of agarose protein A beads 
(or with protein A beads alone as a control) for 2 h at 4°C. After wash-
ing of the beads with 3 × 1 ml of lysis buffer, proteins were eluted 
with SDS–PAGE sample buffer without DTT (50 mM Tris-HCl, pH 6.8, 
15% [wt/vol] sucrose, 2 mM EDTA, 3% SDS) at 70°C for 15 min.
Live-cell imaging
For live-cell imaging, growth medium was replaced with CO2-inde-
pendent medium (Thermo Fischer Scientific) supplemented with 
0.2 μg/ml tetracycline immediately before filming and covered with 
a layer of mineral oil. Time-lapse sequences were recorded on a 
DeltaVision microscope (Applied Precision, Mississauga, Canada) 
equipped with an environmental chamber heated to 36–37°C as 
measured in the dish. Image stacks of 5 × 3 μm were acquired every 
4 min for 10 h with a CoolSnap charge-coupled device camera 
(Photometrics, Tuscon, AZ) and a 40×/numerical aperture (NA) 1.35 
U-planApo objective (Olympus, Tokyo, Japan) at 2 × 2 binning.
Indirect immunofluorescence and immunoblotting
For immunofluorescence experiments, cells were fixed immediately 
after aspiration of the medium with 4% formaldehyde in Phem buffer 
(60 mM 1,4-piperazinediethanesulfonic acid, 25 mM HEPES, 10 mM 
EGTA, 2 mM MgCl2, pH 6.9) for 5 min at room temperature and then 
approach similar to the one we used here. Of interest, FTI treatment 
in DLD-1 cells had a more pronounced effect on kinetochore levels of 
CENP-E and CENP-F than FTI treatment in HeLa cells, yet the mitotic 
delay caused by FTase inhibition was similar in both cell lines 
(2.2- and 2.5-fold in DLD-1 and HeLa cells, respectively). Taking this 
together with the observation that nonfarnesylated Spindly was 
robustly displaced from kinetochores in both cell lines, we propose 
that loss of Spindly farnesylation is a major factor contributing to the 
mitotic phenotype observed in cells treated with FTIs.
MATERIALS AND METHODS
Cells lines and antibodies
Stable isogenic cell lines expressing Spindly and CENP-E trans-
genes were generated by FRT/Flp-mediated recombination as de-
scribed previously (Tighe et al., 2004). Full-length Spindly and 
CENP-E cDNA corresponding to amino acids 1569–2264 of CENP-
E (CENP-E tail) were cloned into a pcDNA5/FRT/TO-based vector 
(Invitrogen, Carlsbad, CA) modified to contain an N-terminal 
Myc-LAP epitope tag. The LAP tag consists of GFP-TEV-S-peptide 
(Cheeseman et al., 2004). Affinity-purified rabbit polyclonal anti-
bodies against Spindly fragments comprising amino acids 2–254 
(OD173) and 450–605 (OD174) were generated as described previ-
ously (Desai et al., 2003).
Cell culture and RNA interference
HeLa and DLD-1 cells were maintained at 37°C in a 5% CO2 atmo-
sphere in DMEM (Thermo Fischer Scientific, Waltham, MA) supple-
mented with 10% tetracycline-free fetal bovine serum (Clontech, 
Mountain View, CA), 100 U/ml penicillin, 100 U/ml streptomycin, 
and 2 mM l-glutamine. For immunofluorescence, cells were seeded 
on 12-mm poly-l-lysine–coated coverslips in 12-well plates 24 h be-
fore transfection with siRNAs. For live-cell imaging experiments, 
cells were seeded in a 35-mm glass-bottom dish coated with poly-d-
lysine (MatTek, Ashland, MA). Cells were transfected with siRNAs 
targeting Spindly and the CENP-E 3′ UTR as described previously 
(Gassmann et al., 2010; Kim et al., 2010). For immunofluorescence 
of HeLa Flp-In T-Rex cells, transgene expression was induced with 
0.2 μg/ml tetracycline 24 h posttransfection, and cells were fixed 
20–24 h later. For live-cell imaging of HeLa Flp-In T-Rex cells and for 
the immunoblot shown in Figure 5A, transgene expression was in-
duced 22 h after transfection, and time-lapse imaging experiments 
were started 8 h later.
AGOH labeling and drug treatments
For labeling of DLD-1 or HeLa Flp-In T-Rex cells with the farnesol 
analogue AGOH, a confluent 10-cm dish of unsynchronized cells 
was split 1:5 into one 15-cm dish. After 24 h, cells were incubated 
with 30 μM AGOH, 0.2 μg/ml tetracycline, and 10 μM FTI-277 
(Sigma-Aldrich, St. Louis, MO) for 40 h before cells were harvested 
and processed for immunoprecipitation experiments and immuno-
blotting. To depolymerize microtubules before immunofluores-
cence, cells were treated with 1 μM nocodazole for 4 h.
fluorescence microscopy experiments conducted with DLD-1 cells expressing histone H2b::mRFP with or without the 
CENP-E transgenes described in B. Mitotic duration is shown as a scatter plot with the average and SD for the indicated 
experimental conditions. All conditions were filmed in parallel during the same imaging session using a multiwell 
chamber. One hundred cells were scored for each condition. The t test was used to determine statistical significance 
(***p < 0.0001). (E) Quantification of mitotic duration for the indicated conditions from a time-lapse experiment, as 
described in D (ns, not statistically significant). (F) Selected images from a time-lapse series of DLD-1 cells coexpressing 
histone H2b::mRFP and CENP-E transgenes showing chromosome congression defects in cells expressing 
nonfarnesylated CENP-E. Time is indicated in minutes relative to nuclear envelope breakdown (time point 0). Lowercase 
letters refer to the conditions labeled with the same letters in D and E. Scale bar, 5 μm.
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permeabilized for 2 min with 0.1% Triton 
X-100 in Phem buffer and rinsed three times 
in Phem buffer. For stainings with anti-dy-
nein antibodies, cells were fixed in methanol 
at −20°C for 45 min, followed by rehydration 
for 2 × 5 min in PBS/0.5% Triton X-100 and 
PBS/0.1% Triton X-100. Cells were blocked 
for 30 min in AbDil solution (4% immuno-
globulin G–free bovine serum albumin 
[Jackson Immuno Research, West Grove, 
PA], 0.1% Triton X-100) and incubated with 
primary antibody for 1 h at room tempera-
ture (overnight at 4°C for anti-dynein), di-
luted in AbDil (human anti–centromere anti-
bodies [ACAs], 1:1000; rabbit anti-AG, 
1:1000; mouse anti-CENP-E 1H12, 1:500; 
sheep anti-CENP-F, 1:800; mouse anti-dy-
nein IC 70.1, 1:500; mouse anti-dynactin 
p150, 1:150; goat anti-GFP, 1:15000; mouse 
anti-Hec1 9G3, 1:1000; rabbit anti-Spindly 
OD174, 1:5000; rabbit anti-Zwilch, 1:900). 
After washing for 3 × 5 min in PBS/0.1% 
Triton X-100, cells were incubated with sec-
ondary antibodies conjugated with fluores-
cent dyes (Alexa 488, rhodamine red X, Cy5 
[Jackson ImmunoResearch]). Cells were 
washed again for 3 × 5 min and mounted in 
Prolong Gold with 4′,6-diamidino-2-phenyl-
indole stain (Invitrogen). Images were re-
corded on an Axio Observer microscope 
(Carl Zeiss, Oberkochen, Germany) at 1 × 1 
binning with a 100×/NA 1.46 Plan-Apochro-
mat objective and an Orca Flash 4.0 camera 
(Hamamatsu Photonics, Hamamatsu, Japan). 
Maximum intensity projections of z-stacks 
were imported into Photoshop CS5.1 
(Adobe Systems, San Jose, CA) for further 
processing. For quantification of kineto-
chore signals, unprocessed 16-bit images 
were analyzed with Fiji software as described 
FIGURE 5: Preventing farnesylation of Spindly and inhibiting farnesyltransferase result in a 
similar mitotic delay. (A) Immunoblot showing expression levels of endogenous and RNAi-
resistant, transgene-encoded MycGFP::Spindly. Cells were treated with control or Spindly siRNA 
for 22 h, followed by induction of transgene expression with 0.2 μg/ml tetracycline for 8 h. 
α-Tubulin was used as a loading control. 
(B) Quantitative analysis of mitotic duration 
(nuclear envelope breakdown to anaphase 
onset) for time-lapse fluorescence 
microscopy experiments performed with 
HeLa cells expressing histone H2b::mRFP 
with or without Spindly transgenes. RNAi and 
induction of transgene expression was 
performed as for the immunoblot in A. Data 
are shown as scatter plots with average and 
SD. Two independent experiments were 
performed for each condition, and the total 
number (n) of cells scored is indicated. The 
t test was used to determine statistical 
significance (***p < 0.0001; *p < 0.05). 
(C) Selected images from the time-lapse 
experiments described in B, showing 
chromosome congression defects in cells 
expressing the Spindly farnesylation mutant 
C602S. Time is indicated in minutes relative 
to nuclear envelope breakdown (time point 
0). Scale bar, 5 μm.
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